Under construction – not a live service
Sign in
Taking people in Hong KongPhase 2/3

Tests a herbal formula for eczema in children against a placebo

Tests a herbal granule formula against placebo for eczema in children aged 4 to 17.

Key facts

Who runs it
Chinese University of Hong Kong
Where
Hong Kong, Hong KongSee the site
Trial code
Registry title
Evaluate the Efficacy of Using Modified Qing-Ying Decoction in Atopic Dermatitis Children
Status
Recruiting
Phase
Phase 2/3
People taking part
64 people, planned
Started
10 Sept 2020
Expected to end
Aug 2027
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Modified Qing-Ying Decoction
  • Identical looking placebo
Record updated
30 July 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for children and teenagers aged 4 to 17 with subacute or chronic atopic dermatitis (eczema). It tests a herbal granule drink against a placebo for 12 weeks.

Age
4 to 17 years (Chinese only)
Sex
All sexes can join.
Disease stage
Subacute or chronic atopic dermatitis with dry, scaly, red bumps and patches on the skin. EASI score of 10 or more.
Earlier treatment
Must not have taken oral corticosteroids, oral antibiotics, other immunosuppressive drugs or oral herbal medicines for atopic dermatitis in the past month. Must not have taken anti-coagulant or anti-platelet drugs, probiotics or prebiotics in the past month.

Main reasons for not taking part

  • Allergy to Chinese medicines
  • Known bacterial skin infection
  • Known pregnancy
  • Severe heart, liver or kidney problems, or diabetes
  • Known G6PD deficiency

The registry criteria, word for word

Show all 14 criteriaShow less

Who can take part

  • Age of 4 to 17 (Chinese only)
  • With EASI ≥ 10
  • Subacute and chronic atopic dermatitis presenting with dry, scaly, erythematous papules and plaques; and
  • Provide written informed consent form (signed by one of their parents)

Who cannot take part

  • Having used oral corticosteroids, oral antibiotics, other immunosuppressive or any preparation of oral herbal medicines for the treatment of AD in the past month
  • History of allergy to Chinese medicines
  • AD with Yang deficiency in syndrome differentiation, such as pale looking, always feeling cold, fatigue, chronic diarrhea with loose stool, urinary disorders such as urinary difficulty, excessive urination or incontinence
  • Known overt bacterial infections in the skin
  • Known severe medical conditions, such as cardiovascular, liver or renal dysfunction or Diabetes Mellitus
  • Having been diagnosed with scabies, allergic contact dermatitis, seborrheic dermatitis or psoriasis; and
  • Has taken anti-coagulant or anti-platelet drugs in the past month
  • Known history of glucose-6-phosphate dehydrogenase (G6PD) deficiency
  • Known pregnancy
  • Has taken any probiotics, prebiotics in the last month

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 4 and 17 years old?

Where in Hong Kong

  • The Chinese University of Hong KongHong Kong, Hong KongContact: Zhi-xiu Lin, PhDTaking people

About the trial

What the trial wants to find out

The study aims to evaluate the clinical efficacy and safety of the modified Qing-Ying Decoction (mQYD) for the treatment of subacute and chronic atopic dermatitis (AD) in children when compared to the placebo control through examining the clinical symptoms, quality of life, gut microbiome, and Chinese medicine body constitution.

Read full original descriptionShow less

This is a parallel, randomized, placebo-controlled, double-blind clinical trial. Eligible subjects will be randomly allocated to receive oral mQYD granules or it's placebo granules. Subjects will have 12-week of treatment, and then a 4-week follow-up.

The 2 groups in the trial

  • Modified Qing-Ying DecoctionTreatment being tested

    Herbal granules, twice per day for 12 weeks

  • Identical looking placeboPlacebo, for comparison

    Placebo granules, twice per day for 12 weeks

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
A Randomized Placebo-Controlled Clinical Trial of an Innovative Herbal Formula for Atopic Dermatitis in Children: Evaluations of Modified Qing-Ying Decoction on Efficacy and Gut Microbiome
Plain-language title
Tests a herbal formula for eczema in children against a placeboGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT04419584, who can take part
Record updated
30 July 2026